HCA Healthcare stock jumps on conference remarks and Wall Street support

Published on 09/10/2026 at 19:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock traded at USD 422.47 on September 10, 2026, after a 4.9 percent rise on September 9. Second-quarter 2026 revenue was USD 20.23 billion and EPS was USD 7.59.

Fotorealistisches Krankenhaus-Außengebäude mit Ambulanzen am Haupteingang bei Sonnenuntergang — HCA Healthcare US40412C1018 zeigt einen modernen Krankenhaus Campus mit Notaufnahme bei goldenem Abendlicht, Illustration mit AI erstellt.

HCA Healthcare stock (ISIN US40412C1018) traded at USD 422.47 on September 10, 2026, after a 4.9 percent rise on September 9. MarketBeat said the shares opened at USD 422.47, with a market capitalization of USD 91.47 billion and a 52-week range of USD 353.99 to USD 556.52.

Conference remarks lift the tone

As Nashville Post reported on September 10, 2026, HCA stock had its third-best single-session day of 2026 after company officials at the Wells Fargo 21st Annual Healthcare Conference highlighted patient volume projections and margin stability. The same report tied the move to positive updates on demand and execution.

That backdrop mattered because HCA Healthcare's second-quarter 2026 revenue was USD 20.23 billion, EPS was USD 7.59 and revenue increased 8.7 percent from USD 18.61 billion a year earlier. MarketBeat said that EPS beat the consensus estimate of USD 7.56 by USD 0.03 and that revenue topped the USD 19.76 billion forecast.

Wall Street stays constructive

According to TipRanks on September 9, 2026, a USD 435 price target and renewed confidence helped the market look past trimmed 2026 profit guidance. MarketBeat put the consensus target at USD 462.64 and the consensus rating at Moderate Buy.

For investors, the current setup is less about headline price and more about whether the USD 20.23 billion quarter and the 8.7 percent growth rate can carry the business into the next reporting period. The stock remains close to the upper half of its 52-week band, with a 200-day moving average of USD 434.23 in MarketBeat's data.

Price and level

HCA Healthcare stock was at USD 422.47 on September 10, 2026. MarketBeat also listed a market capitalization of USD 91.47 billion, a 52-week low of USD 353.99 and a 52-week high of USD 556.52.